ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 680399 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 680399; 2) Community: the network communities that were significantly associated with the response to NSC 680399; 3) Molecule: the relationships between components within communities and NSC 680399; 4) MDR: the compounds that were significantly associated with the NSC 680399.

NSC Compound Enrichment Correlation
NSC 671184 Null 0.0112425217758227 0.10661199
NSC 685272 D-Glucose, [4-[(4-chlorophenyl)methylene]-5-oxo- 2-imidazolidinylidene]hydrazone 0.0112425217758227 0.34252544
NSC 681632 Camptothecin Derivative 0.0114553853234976 0.13570733
NSC 710002 Null 0.0114553853234976 -0.073357487
NSC 715974 Null 0.0114553853234976 0.24585442
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0114553853234976 0.21953054
NSC 748643 Mitaplatin 0.0114553853234976 0.10120483
NSC 100880 Camptothecin 0.0114553853234977 0.0069649496
NSC 300289 Pinafide 0.0114553853234977 0.067549788
NSC 615291 Bizelesin 0.0114553853234977 0.08380547
Total:37  Current:7    [First] [Prev] [Next] [Last]